Thrombin generation assay: An appropriate test for research and necessary in the modern assessment of hemostasis;Le test de génération de thrombine Un test utile pour la recherche et nécessaire pour une exploration moderne de l'hémostase

Bio Tribune Magazine

Volumn 24, Issue 1, 2007, Pages 37-43

  Gerotziafas, G T ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

CAT; Thrombin generation assay; Thrombinography; Thrombogram

Indexed keywords

EID: 70349271217     PISSN: 17729416     EISSN: 1951655X     Source Type: Journal    
DOI: 10.1007/BF03010326     Document Type: Article

References (33)

1. Samama MM, Gerotziafas GT, Elalamy I, et al. (2002). Biochemistry and clinical pharmacology of new anticoagulant agents. Pathophysiol Haemost Thromb 32(SUPPL. 1): 1-4
2. Josso F, Prou-Wartelle O (1965). Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haermorrh 17: 35-44
3. Hemker HC, Beguin S (2000). Phenotyping the clotting system. Thromb Haemost 84: 741-51
4. Mann KG, Butenas S, Brummel K (2003). The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 23: 17-25
5. Butenas S, Mann K (2002). Blood coagulation. Biochemistry 67: 3-12
6. Giesen PLA, Rauch U, Bohrmann B, et al. (1999). Blood borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 96: 2311-5
7. Provenzale L, Casolo P, Bifani I (1952). Value of an original thrombogram in the early diagnosis of thrombosis and the recognition of potential thrombosis. Policlinico Chir 59: 257-79
8. Macfarlane RG, Biggs R (1953). A thrombin generation test. J Clin Pathol 6: 3-7
9. Pitney WR, Dacie J (1953). A simple method of studying the generation of thrombin in recalcified plasma. J Clin Pathol 6: 9-13
10. Seegers WH (1981). A personal perspective on hemostasis and thrombosis (1937-1981). Semin Thromb Hemost 7: 177-307
11. Houbouyan L, Padilla A, Gray E, et al. (1996). Inhibition of thrombin generation by heparin and LMW heparins: a comparison of chromogenic and clotting methods. Blood Coagul Fibrinolysis 7: 24-30
12. Hemker HC, Wielders S, Kessels H, et al. (1993). Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 70: 617-24
13. Hemker HC, Willems GM, Beguin S (1986). A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 56: 9-17
14. Hemker HC, Giesen PL, Ramjee M, et al. (2000). The thrombogram: monitoring thrombin génération in platelet-rich plasma. Thromb Haemost 83: 589-91
15. Hemker HC, Ai Dieri R, De Smedt E, et al. (2006). Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96: 553-61
16. Regnault V, Beguin S, Lecompte T (2003). Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb 33: 23-9
17. Gerotziafas GT, Depasse F, Busson J, et al. (2005). Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of thrombogram-thrombinoscope assay. Thrombosis J 3: 16
18. Dargaud Y, Luddington R, Gray E, et al. (2007). Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol 139: 303-9
19. Vanschoonbeek K, Feijge MA, van Kampen RJ (2004). Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2: 476-84
20. Allen GA, Wolberg AS, Oliver JA, et al. (2004). Impact of procoagulant concentration on rate, peak and total thrombin generation in a cell based model syste. J Thromb Haemost 2: 402-13
21. Dargaud Y, Bordet JC, Francillon S, et al. (2007). Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant? Thromb Haemost 97: 675-6
22. Petropoulou AD, Gerotziafas GT, Samama MM, et al. (2006). In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide. Thromb Res (sous presse)
23. Regnault V, Beguin S, Wahl D, et al. (2003). Thrombinography shows acquire resistance to activated protein C in patients with lupus anticoagulants. Thromb Haemost 89: 208-12.
24. Wielders S, Mukherjee M, Michiels J, et al. (1997). The routine determination of the endogenous thrombin potential, first results in different forms of hyper-and hypocoagulability. Thromb Haemost 77: 629-36
25. Nicolaes GA, Thomassen MC, Tans G, et al. (1997). Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals. Blood Coagul Fibrinolysis 8: 28-38
26. Dargaud Y, Trzeciak MC, Bordet JC, et al. (2006). Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 96: 562-7
27. Hezard N, Bouaziz-Borgi L, Remy MG, et al. (2006). Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency. Clin Chem 52: 665-70
28. Gerotziafas GT, Zervas K, Arzoglou P, et al. (2002). On the mechanism of action of rFVIIa administered to patients with severe thrombocytopenia and life-threatening haemorrhage. Focus on prothrombin activation. Br J Hematol 117: 705-8
29. Gerotziafas GT, Zervas K, Arzoglou P, et al. (2002). On the mechanism of action of rFVIIa administered to patients with severe thrombocytopenia and life-threatening haemorrhage. Focus on prothrombin activation. Br J Hematol 117: 705-8
30. Gerotziafas GT, Depasse F, Chakroun T, et al. (2004). Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in vitro clotting of whole blood and platelet rich plasma. Blood Coagul Fibrinolysis 15(2): 149-56
31. Gerotziafas GT, Petropoulou AD, Verdy E, et al. (2007). Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation. J Thromb Haemost 5: 955-62.
32. Gerotziafas GT, Elalamy I, Depasse F, et al. (2007). In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban. J Thromb Haemost 5: 886-8.
33. Bostrom SL, Hansson GF, Kjaer M, et al. (2003). Effects of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, and dalteparin on the endogenous thrombin potential in venous blood from healthy male subjects. Blood Coagul Fibrinolysis 14: 457-62.